000 02435 a2200673 4500
005 20250516070901.0
264 0 _c20120320
008 201203s 0 0 eng d
022 _a1474-5488
024 7 _a10.1016/S1470-2045(11)70300-X
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTrappe, Ralf
245 0 0 _aSequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial.
_h[electronic resource]
260 _bThe Lancet. Oncology
_cFeb 2012
300 _a196-206 p.
_bdigital
500 _aPublication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAntibodies, Monoclonal, Murine-Derived
_xadministration & dosage
650 0 4 _aAntigens, CD20
_ximmunology
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xadministration & dosage
650 0 4 _aCyclophosphamide
_xadministration & dosage
650 0 4 _aDoxorubicin
_xadministration & dosage
650 0 4 _aEpstein-Barr Virus Infections
_xdiagnosis
650 0 4 _aFemale
650 0 4 _aFrance
650 0 4 _aGermany
650 0 4 _aHerpesvirus 4, Human
_xpathogenicity
650 0 4 _aHumans
650 0 4 _aLymphoproliferative Disorders
_xdrug therapy
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aOrgan Transplantation
_xadverse effects
650 0 4 _aPrednisolone
_xadministration & dosage
650 0 4 _aProspective Studies
650 0 4 _aRituximab
650 0 4 _aVincristine
_xadministration & dosage
700 1 _aOertel, Stephan
700 1 _aLeblond, Veronique
700 1 _aMollee, Peter
700 1 _aSender, Monica
700 1 _aReinke, Petra
700 1 _aNeuhaus, Ruth
700 1 _aLehmkuhl, Hans
700 1 _aHorst, Heinz August
700 1 _aSalles, Gilles
700 1 _aMorschhauser, Franck
700 1 _aJaccard, Arnaud
700 1 _aLamy, Thierry
700 1 _aLeithäuser, Malte
700 1 _aZimmermann, Heiner
700 1 _aAnagnostopoulos, Ioannis
700 1 _aRaphael, Martine
700 1 _aRiess, Hanno
700 1 _aChoquet, Sylvain
773 0 _tThe Lancet. Oncology
_gvol. 13
_gno. 2
_gp. 196-206
856 4 0 _uhttps://doi.org/10.1016/S1470-2045(11)70300-X
_zAvailable from publisher's website
999 _c21395083
_d21395083